Role of advanced glycation end products and insulin resistance in diabetic nephropathy

被引:45
|
作者
Parwani, Kirti [1 ]
Mandal, Palash [1 ]
机构
[1] Charotar Univ Sci & Technol, PD Patel Inst Appl Sci, Dept Biol Sci, Changa 388421, Gujarat, India
关键词
Advanced glycation end products; insulin resistance; receptor for advanced glycation end products; endoplasmic reticulum stress; diabetic nephropathy; ENDOPLASMIC-RETICULUM STRESS; INDUCED PODOCYTE APOPTOSIS; UNFOLDED PROTEIN RESPONSE; OXIDATIVE STRESS; METABOLIC SYNDROME; CARDIOVASCULAR-DISEASE; URSODEOXYCHOLIC ACID; DOWN-REGULATION; ELEVATED LEVELS; RECEPTOR;
D O I
10.1080/13813455.2020.1797106
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Metabolic syndrome (MetS), i.e. a cluster of physiological and biochemical abnormalities can lead to diabetic nephropathy (DN). Insulin resistance, impaired fasting glucose are the main signs and symptoms of MetS. Excess sugar can induce various substantial structural changes like formation of advanced glycation end products (AGEs). AGEs are formed due to reaction of reducing sugars with amino groups of proteins, lipids and nucleic acids. AGEs when bound to the receptor for advanced glycation end products (RAGE) activate increased production of pro-inflammatory markers like interleukin-6 (IL-6), tumour necrosis factor alpha (TNF-alpha) along with induction of endoplasmic reticulum (ER) stress. Accumulation of AGEs, enhanced reactive oxygen species (ROS) generation and activation of protein kinase C (PKC), are considered to induce glomerular hypertrophy, podocyte apoptosis, therefore contributing to the development and progression of DN. In this review, we decipher different biochemical and physiological factors that link AGEs and DN.
引用
收藏
页码:95 / 107
页数:13
相关论文
共 50 条
  • [41] Serum advanced glycation end products is associated with insulin resistance independent of adiponectin
    Tan, K. C. B.
    Shiu, S. W. M.
    Wong, Y.
    Tam, X.
    DIABETOLOGIA, 2010, 53
  • [42] Advanced glycation end products decrease mesangial cell MMP-7: A role in matrix accumulation in diabetic nephropathy?
    McLennan, S. V.
    Kelly, D. J.
    Schache, M.
    Waltham, M.
    Dy, V.
    Langham, R. G.
    Yue, D. K.
    Gilbert, R. E.
    KIDNEY INTERNATIONAL, 2007, 72 (04) : 481 - 488
  • [43] INTERACTIONS BETWEEN ADVANCED GLYCATION END PRODUCTS (AGES) AND THEIR RECEPTORS IN PRIMARY RENAL CELLS AND THEIR ROLE IN THE PROGRESSION OF DIABETIC NEPHROPATHY
    Harcourt, B. E.
    Penfold, S.
    Tan, A.
    Yap, F.
    Gasser, A.
    Fukami, K.
    Cooper, M. E.
    Forbes, J. E.
    NEPHROLOGY, 2006, 11 : A29 - A29
  • [44] Inhibition of advanced glycation end products - An implicit goal in clinical medicine for the treatment of diabetic nephropathy?
    Miyata, Toshio
    Izuhara, Yuko
    MAILLARD REACTION: RECENT ADVANCES IN FOOD AND BIOMEDICAL SCIENCES, 2008, 1126 : 141 - 146
  • [45] Early Progression of Diabetic Nephropathy Correlates With Methylglyoxal-Derived Advanced Glycation End Products
    Beisswenger, Paul J.
    Howell, Scott K.
    Russell, Gregory B.
    Miller, Michael E.
    Rich, Stephen S.
    Mauer, Michael
    DIABETES CARE, 2013, 36 (10) : 3234 - 3239
  • [46] The glomerular localization of CML and non-CML advanced glycation end products in diabetic nephropathy
    Yanagisawa, K
    Ueno, H
    Takeuchi, M
    Iriyama, R
    Makita, Z
    Koike, T
    DIABETES, 1998, 47 : A372 - A372
  • [47] Deletion of the receptor for advanced glycation end products, RAGE, protects from diabetic nephropathy and atherosclerosis
    Jandeleit-Dahm, K. A. M.
    Yong, J.
    Jiaze, L.
    Barit, D.
    Soro-Paavonen, A.
    Giunti, S.
    Watson, A.
    Bierhaus, A.
    Allen, T.
    Cooper, M.
    DIABETOLOGIA, 2008, 51 : S44 - S44
  • [48] Role of advanced glycation end products and sorbitol dehydrogenase in the pathogenesis of diabetic retinopathy
    Leqaa A. Moemen
    Mona A. Abdel Hamid
    Soher Abdel Wahab
    Mahmoud Kenawy M. Kenawy
    Manal H. Abuelela
    Olfat A. Hassanin
    Marwa A. Fouly
    Amira A. Abdelazeem
    Shahira Riad Noweir
    Somaia M. Ismail
    Yara Hossam Eldin R. Abdel Gawad
    Safa Refaat
    Azza K. Amer
    Nervana A. Khalaf
    Safya H. Aboelmakarem
    Mehry S. Elsobky
    Mona R. Abdelrasool
    Sherif S. Karawya
    Zeinab M. Osman
    Bulletin of the National Research Centre, 44 (1)
  • [49] Role of Receptor for Advanced Glycation End Products (RAGE) in Regression of Diabetic Atherosclerosis
    Senatus, Laura M.
    Lopez-Diez, Raquel
    Liu, Jianhua
    Li, Huilin
    Daffu, Gurdip
    Li, Qing
    Rahman, Karishma
    Vengrenyuk, Yuliya
    Barrett, Tessa
    Friedman, Richard
    Ramasamy, Ravichandran
    Fisher, Edward
    Schmidt, AnnMarie
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2017, 37
  • [50] ROLE OF ADVANCED GLYCATION END-PRODUCTS (AGE) IN LATE DIABETIC COMPLICATIONS
    SENSI, M
    PRICCI, F
    PUGLIESE, G
    DEROSSI, MG
    PETRUCCI, AFG
    CRISTINA, A
    MORANO, S
    POZZESSERE, G
    VALLE, E
    ANDREANI, D
    DIMARIO, U
    DIABETES RESEARCH AND CLINICAL PRACTICE, 1995, 28 (01) : 9 - 17